FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...
The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.
Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.
Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...
Medtronic earned the FDA’s 510(k) clearance for its Stealth AXiS system that brings planning, navigation and robotics into ...
Grounded in more than 50 years of Medtronic leadership in surgical navigation and robotics, the Stealth AXiS™ system creates a clear pathway for adoption by combining familiar navigation workflows ...
Medtronic built the Stealth AXiS system to support a wide range of surgeon preferences, clinical complexity, and care settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results